Intrinsiqs

Is Kyverna Therapeutics, Inc. overvalued?

Kyverna Therapeutics, Inc. (KYTX) — key valuation metrics and fundamentals.

No verdict
Price
$5.05
Fair value
—
Current P/E
—
Normal P/E
—
Market cap
$312.3M
Dividend yield
0.0%
Return on equity
-86.9%
Sector
Healthcare

See the full interactive analysis →

Fair value compares KYTX's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 12 Nov 2026.